JPH05236974A - Production of highly unsaturated fatty acid-containing phospholipid - Google Patents
Production of highly unsaturated fatty acid-containing phospholipidInfo
- Publication number
- JPH05236974A JPH05236974A JP9127291A JP9127291A JPH05236974A JP H05236974 A JPH05236974 A JP H05236974A JP 9127291 A JP9127291 A JP 9127291A JP 9127291 A JP9127291 A JP 9127291A JP H05236974 A JPH05236974 A JP H05236974A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- phospholipid
- unsaturated fatty
- highly unsaturated
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、Sn2位に高度不飽和
脂肪酸を含有するリン脂質を酵素反応により製造する方
法に関する。TECHNICAL FIELD The present invention relates to a method for producing a phospholipid containing a highly unsaturated fatty acid at the Sn2 position by an enzymatic reaction.
【0002】[0002]
【従来の技術】リン脂質の種々の生理活性については近
年明らかになりつつある。例えばエイコサペンタエン酸
含有リン脂質は、同量の脂肪酸量において、トリグリセ
ライドやエチルエステルに比較してその生理活性が高い
ことが知られている。また、養魚飼料においても、ある
種の仔魚にはリン脂質が必須の栄養素である。また、リ
ン脂質内で脂肪酸の占める位置も、その活性発現に大き
く影響することが明らかとなってきている。養魚飼料に
おいては、Sn2位に不飽和脂肪酸を有するリン脂質
が、添加効果が高いことが知られている。また、人間の
生体内においては、リン脂質はSn2位に不飽和脂肪酸
を有するものが多く、ホスホリパーゼA2 によりリン脂
質のSn2位から切り出された高度不飽和脂肪酸が例え
ばプロスタグランジンの基質となる等、様々な生理活性
の発現に寄与することは広く知られている。2. Description of the Related Art Various physiological activities of phospholipids have recently become clear. For example, eicosapentaenoic acid-containing phospholipid is known to have higher physiological activity than triglyceride or ethyl ester at the same amount of fatty acid. Also, in fish feed, phospholipids are essential nutrients for certain larvae. Further, it has been revealed that the position of fatty acid in the phospholipid has a great influence on its activity expression. It is known that phospholipids having an unsaturated fatty acid at the Sn2 position have a high addition effect in fish feeds. In humans, most phospholipids have unsaturated fatty acids at the Sn2 position, and highly unsaturated fatty acids cut out from the Sn2 position of phospholipids by phospholipase A 2 serve as substrates for prostaglandins, for example. It is widely known that it contributes to the expression of various physiological activities.
【0003】第62回日本生化学大会において松本ら
は、Sn2位にドコサヘキサエン酸を有するホスファジ
ルコリンが、アラキドン酸のロイコトリエンへの転換に
対し、強い抑制能を示したことを報告している。その中
でSn1位、Sn2位にそれぞれオレイン酸、ドコサヘ
キサエン酸を有するホスファチジルコリンが、両方にド
コサヘキサエン酸を有するホスファチジルコリンよりも
その抑制能が著しく高いことも報告している。At the 62nd Japan Biochemical Congress, Matsumoto et al. Reported that phosphadylcholine having docosahexaenoic acid at Sn2 position showed a strong inhibitory effect on the conversion of arachidonic acid to leukotriene. Among them, it is also reported that phosphatidylcholine having oleic acid and docosahexaenoic acid at Sn1 position and Sn2 position, respectively, has significantly higher inhibitory activity than phosphatidylcholine having docosahexaenoic acid at both positions.
【0004】以上のように、リン脂質の生理活性発現に
は、単にその脂肪酸組成のみではなく、その脂肪酸の占
める位置も重要な意味を持つことが明らかになってい
る。リン脂質は、天然に広く存在するが、今日、医療・
食品等の分野で利用されているリン脂質の抽出源のほと
んどは、大豆と卵黄である。その脂肪酸組成は、大豆リ
ン脂質ではリノール酸、卵黄リン脂質ではパルミチン
酸、オレイン酸を多く含むという特徴を有していて、い
ずれにも3個以上の二重結合を持つ高度不飽和脂肪酸
は、わずかしか含まれていない。As described above, it has been revealed that not only the composition of the fatty acid but also the position occupied by the fatty acid is important for the expression of the physiological activity of the phospholipid. Phospholipids are widespread in nature, but today medical and
Most of the extraction sources of phospholipids used in the fields of food and the like are soybean and egg yolk. The fatty acid composition is characterized in that soybean phospholipids contain a large amount of linoleic acid, and egg yolk phospholipids contain a large amount of palmitic acid and oleic acid. In each case, highly unsaturated fatty acids having three or more double bonds are Very little is included.
【0005】一方、動物組織中のリン脂質は、一般に高
度不飽和脂肪酸を多く含んでいるが、そのリン脂質含有
量は少なく、かつ蓄積脂肪とは異なり蛋白質に強固に結
合しているために、これを抽出することは容易ではな
い。これまでに酵素反応により希望する脂肪酸組成のリ
ン脂質を得ようとする試みが報告されている。吉本ら
は、ポリエチレングリコール修飾リパーゼによりエイコ
サペンタエン酸をホスファチジルコリン内に導入してい
る(BIOTECHNOLOGY LETTERS VOL.8,pp771-776,1986) 。
また、戸谷らは、大豆リン脂質と魚油間でのリパーゼに
よるエステル交換を行っている(平成2年第44回日本
栄養・食糧学会総会講演要旨)。更に、八木らは、リン
脂質と脂肪酸間のリパーゼによるアシル基交換反応につ
いて報告している(JOURNAL OF FERMENTATION AND BIOE
NGINEERING VOL.69,pp23-25,1990) 。On the other hand, phospholipids in animal tissues generally contain a large amount of highly unsaturated fatty acids, but their phospholipid content is low and, unlike accumulated fat, they are strongly bound to proteins, It is not easy to extract this. An attempt to obtain a phospholipid having a desired fatty acid composition by an enzymatic reaction has been reported so far. Yoshimoto et al. Introduced eicosapentaenoic acid into phosphatidylcholine by using a polyethylene glycol-modified lipase (BIOTECHNOLOGY LETTERS VOL.8, pp771-776, 1986).
In addition, Toya et al. Are transesterifying soybean phospholipid and fish oil with lipase (abstract of the 44th Annual Meeting of the Japanese Society of Nutrition and Food Science in 1990). In addition, Yagi et al. Reported on the acyl group exchange reaction by lipase between phospholipids and fatty acids (JOURNAL OF FERMENTATION AND BIOE
NGINEERING VOL.69, pp23-25, 1990).
【0006】一方、特許でも、リン脂質と任意の脂肪酸
または脂肪酸エステルとから、酵素によるエステル交換
により、その脂肪酸の組成を変えるものが提示されてい
る(特開昭63ー105686 号、 特開昭63-185391 号、 特開平
2-35093 号) 。On the other hand, the patent also proposes a method in which a phospholipid and an arbitrary fatty acid or fatty acid ester are used to change the composition of the fatty acid by transesterification by an enzyme (JP-A-63-105686, JP-A-SHO-106686). 63-185391, JP-A
2-35093).
【0007】[0007]
【発明が解決しようとする課題】しかし、上記の報告例
あるいは先願特許はいずれも、導入される脂肪酸はリン
脂質のSn1位若しくはSn2位にランダムに入るか、
またはSn1位に優先的に入るというもので、Sn2位
に選択的に脂肪酸を導入するものではない。更に、エス
テル交換率が低かったり、或は反応中にリン脂質の加水
分解が行われリゾ型リン脂質が生成しリン脂質の回収率
が低下する、等の問題点もあり、実用化には大きな困難
を抱えていることが明らかである。However, in any of the above-mentioned reported examples or prior patents, the introduced fatty acid randomly enters Sn1 position or Sn2 position of phospholipid,
Alternatively, the Sn1 position is preferentially entered, and the fatty acid is not selectively introduced into the Sn2 position. Further, there are problems such as low transesterification rate, or hydrolysis of phospholipids during the reaction to form lyso-type phospholipids, which lowers the recovery rate of phospholipids. It is clear that there are difficulties.
【0008】以上の問題点を解決し、Sn2位に高度不
飽和脂肪酸を導入するために、ホスホリパーゼA2 を使
用する方法を検討した。ホスホリパーゼA2 はリン脂質
のSn2位にのみ作用する酵素であり、これを用いてリ
ン脂質から、加水分解により乳化性の優れたリゾ型リン
脂質を製造する方法は、数多くの特許も出され、実用化
もされている(特開昭62-262998 号、 特開昭63-279753
号、 特開昭63-134042号、 特開昭63-209742 号、 特開平2
-113891号) 。A method of using phospholipase A 2 for solving the above problems and introducing a polyunsaturated fatty acid at the Sn2 position was examined. Phospholipase A 2 is an enzyme that acts only on the Sn2 position of phospholipids, and a method for producing a lyso-type phospholipid excellent in emulsifying property by hydrolysis from phospholipids using this has been issued many patents, It has been put to practical use (Japanese Patent Laid-Open Nos. 62-262998 and 63-279753).
No. 3, JP-A-63-134042, JP-A-63-209742, JP-A-2
-113891).
【0009】この酵素ホスホリパーゼA2 が、加水分解
のみならずその逆の反応である合成をも行うことは広く
知られており、例えば日本油化学協会編油脂化学便覧
(平成2年2月)には「例えばホスホリパーゼA2 を使
用したときの生成物は1−アシルグリセロホスホコリン
+脂肪酸であり、あいた2−位には所望する脂肪酸を導
入することができる。」との記載もある。It is widely known that this enzyme phospholipase A 2 performs not only hydrolysis but also the reverse reaction, and synthesis is described in, for example, Handbook of Oil and Fat Chemistry edited by Japan Oil Chemistry Association (February 1990). "For example, when phospholipase A 2 is used, the product is 1-acylglycerophosphocholine + fatty acid, and a desired fatty acid can be introduced at the 2-position."
【0010】この酵素を用いてリゾ型リン脂質と脂肪酸
とからリン脂質を合成する方法について報告例は極めて
少ないが存在する。P.PERNASらは、水無添加、無極性有
機溶媒中という条件で、種々のホスホリパーゼA2 を用
いてリゾホスファジチルコリンとオレイン酸からホスフ
ァチジルコリンを合成している(BIOCHEMICAL AND BIOP
HYSICAL RESEARCH COMMUNICATION Vol.168,pp644-650,1
990)。また、An Na らは、乳化剤AOTを使用し、豚膵
臓ホスホリパーゼA2 を用いてリゾホスファチジルコリ
ンと高度不飽和脂肪酸とからホスファチジルコリンを合
成している(JOURNAL OF AMERICAN OIL CHEMIST'S SOCI
ETY VOL.67,pp766-770,1990)。There are very few reports on methods for synthesizing phospholipids from lyso-type phospholipids and fatty acids using this enzyme, although there are very few reports. P.PERNAS et al. Synthesize phosphatidylcholine from lysophosphatidylcholine and oleic acid using various phospholipase A 2 under the condition that water is not added and it is in a nonpolar organic solvent (BIOCHEMICAL AND BIOP).
HYSICAL RESEARCH COMMUNICATION Vol.168, pp644-650,1
990). An Na et al. Synthesize phosphatidylcholine from lysophosphatidylcholine and highly unsaturated fatty acids using porcine pancreatic phospholipase A 2 using an emulsifier AOT (JOURNAL OF AMERICAN OIL CHEMIST'S SOCI
ETY VOL.67, pp766-770, 1990).
【0011】しかし、前者でのホスファチジルコリン合
成率は、蛇毒ホスホリパーゼA2 を用いた場合の6.5 %
が最高値で、牛や豚の膵臓ホスホリパーゼA2 を用いた
場合、その合成率はその半分以下となっている。後者で
もそのホスファチジルコリン合成率は約6 %であり、い
ずれの例でも極めて低い合成率である。However, the phosphatidylcholine synthesis rate in the former case was 6.5% when the snake venom phospholipase A 2 was used.
Is the highest value, and when bovine or porcine pancreatic phospholipase A 2 is used, the synthesis rate is less than half of that. Even in the latter case, the synthesis rate of phosphatidylcholine is about 6%, and the synthesis rate is extremely low in all cases.
【0012】[0012]
【課題を解決するための手段】発明者らは、前記技術課
題を解決するため、Sn1位にアシル基を有するリゾ型
リン脂質と、高度不飽和脂肪酸又はそのエステルとか
ら、酵素ホスホリパーゼA2 の酵素反応によりSn2位
に高度不飽和脂肪酸を有するリン脂質を得る際、反応系
にグリセロールを添加することを特徴とする高度不飽和
脂肪酸含有リン脂質の製造方法を開発した。[Means for Solving the Problems] In order to solve the above technical problems, the inventors of the present invention have developed an enzyme phospholipase A 2 from a lyso-type phospholipid having an acyl group at the Sn1 position and a highly unsaturated fatty acid or its ester. When a phospholipid having a highly unsaturated fatty acid at the Sn2 position is obtained by an enzymatic reaction, glycerol was added to the reaction system to develop a method for producing a highly unsaturated fatty acid-containing phospholipid.
【0013】リゾ型リン脂質はアシル基を一つしか有し
ていないため親水性が高く、無極性有機溶媒には極めて
溶解度が低い。リゾ型リン脂質のアシル基を切断する酵
素であるリゾホスホリパーゼ活性のアッセイ系では、全
くの水系で操作を行うのが通例である。しかし、この様
な水系で合成を試みた結果、合成反応は全く進行しなか
った。これは過剰な水の存在のため、反応が分解方向に
しか進まなかったものと思われた。この結果を踏まえ、
リゾ型リン脂質を均一に溶解することができ、かつ酵素
による合成反応を阻害しない物質を探索する中で、グリ
セロールが優れてこれに適合する物質であることを見出
した。Since lyso-type phospholipids have only one acyl group, they are highly hydrophilic and have extremely low solubility in nonpolar organic solvents. In the assay system for the activity of lysophospholipase, which is an enzyme that cleaves the acyl group of lysophospholipids, it is customary to operate in a completely aqueous system. However, as a result of attempting the synthesis in such an aqueous system, the synthetic reaction did not proceed at all. It was considered that the reaction proceeded only in the decomposition direction due to the presence of excess water. Based on this result,
In the search for a substance capable of uniformly dissolving lysophospholipid and not inhibiting the synthetic reaction by the enzyme, it was found that glycerol is a substance which is excellent and suitable for this.
【0014】リゾ型リン脂質の原料としては、Sn1位
にアシル基を有するリゾ型リン脂質を使用する。大豆リ
ン脂質を原料にホスホリパーゼA2 による酵素分解で製
造されたリゾ型リン脂質が比較的安価にかつ安定した品
質で流通しており、これを必要に応じて分画・精製し利
用することができる。あるいは目標とする生理活性の発
現のためにSn1位にも特定の脂肪酸が要求される場合
もあり、最終的な産物の構造に見合ったリゾ型リン脂質
を使用する必要がある。As a raw material for the lyso-type phospholipid, a lyso-type phospholipid having an acyl group at the Sn1 position is used. Lyso-type phospholipids produced from soybean phospholipids by enzymatic decomposition with phospholipase A 2 are distributed at a relatively low cost and with stable quality, and can be fractionated / purified and used as needed. it can. Alternatively, a specific fatty acid may also be required at the Sn1 position for the expression of the target physiological activity, and it is necessary to use a lyso-type phospholipid that matches the structure of the final product.
【0015】ホスホリパーゼA2 は、蛇毒、ハチ毒、サ
ソリ毒等の毒液や動物の膵臓等に多量に存在する他、動
物の各種臓器、植物、細菌等広く生物界に存在してい
る。この中では動物の膵臓から抽出・精製されたものが
比較的安価で使用しやすい。Phospholipase A 2 is present in large amounts in venoms such as snake venom, bee venom and scorpion venom and in the pancreas of animals, as well as in various organisms such as various organs of animals, plants and bacteria. Of these, those extracted and purified from the pancreas of animals are relatively inexpensive and easy to use.
【0016】高度不飽和脂肪酸とは、炭素数18以上、
不飽和結合3個以上の脂肪酸であり、具体的にはαリノ
レン酸、γリノレン酸、アラキドン酸、エイコサトリエ
ン酸、エイコサテトラエン酸、エイコサペンタエン酸、
ドコサトリエン酸、ドコサテトラエン酸、ドコサペンタ
エン酸、ドコサヘキサエン酸等の脂肪酸を示す。Polyunsaturated fatty acids are those having 18 or more carbon atoms,
A fatty acid having three or more unsaturated bonds, specifically, α-linolenic acid, γ-linolenic acid, arachidonic acid, eicosatrienoic acid, eicosatetraenoic acid, eicosapentaenoic acid,
It shows fatty acids such as docosatrienoic acid, docosatetraenoic acid, docosapentaenoic acid and docosahexaenoic acid.
【0017】[0017]
【実施例1】リゾ型リン脂質(リゾホスファチジルコリ
ン含量99%以上)110mg をグリセロール5ml に良く溶解
し、魚油脂肪酸180mg 、ホスホリパーゼA2 溶液(豚膵
臓ホスリパーゼA260mg を0.5ml の6mM 塩化カルシウム
含有200mM トリス塩酸緩衝液(pH8.0)に溶解したもの)
を加え密栓し、チューブミキサーでよく撹拌の後、スタ
ーラーで毎分1500回転で撹拌しながら25℃48時間反応を
行った。反応終了後、Folch 溶媒(クロロホルムーメタ
ノール(2:1 v/v)溶液に0.2容の水を加える)で分配
し脂質を抽出した。抽出した脂質成分はSep-Pak ケイ酸
カートリッジ(Waters Associates,Inc.)を用いてリン
脂質画分を分画し、薄層クロマトグラフィー-FID検出法
(イアトロスキャン)により展開・分離し、脂質組成比
率を求めた。その結果、ホスファチジルコリン合成率
(反応後の総リン脂質中のホスファチジルコリンの重量
比率)は13.8%であった。基質であるリゾホスファチジ
ルコリン、魚油脂肪酸の脂肪酸組成と、合成されたホス
ファチジルコリンのSn1位、Sn2位の脂肪酸組成と
を表1 に示した。Example 1 Lyso-type phospholipid (lysophosphatidylcholine content 99% or more) 110 mg was well dissolved in 5 ml glycerol, and fish oil fatty acid 180 mg and phospholipase A 2 solution (porcine pancreatic phoslipase A 2 60 mg 0.5 ml containing 6 mM calcium chloride 200 mM). Dissolved in Tris-HCl buffer (pH 8.0))
Was added, the mixture was tightly stoppered, and well stirred with a tube mixer, and then reacted at 25 ° C. for 48 hours while stirring at 1500 rpm with a stirrer. After completion of the reaction, the lipid was extracted by partitioning with Folch solvent (chloroform-methanol (2: 1 v / v) solution added with 0.2 volume of water). The extracted lipid components were separated into phospholipid fractions using Sep-Pak silicic acid cartridge (Waters Associates, Inc.), developed and separated by thin layer chromatography-FID detection method (Iatroscan), and lipids were separated. The composition ratio was determined. As a result, the phosphatidylcholine synthesis rate (the weight ratio of phosphatidylcholine in the total phospholipids after the reaction) was 13.8%. Table 1 shows the fatty acid composition of lysophosphatidylcholine and fish oil fatty acid as substrates and the fatty acid composition of Sn1 position and Sn2 position of the synthesized phosphatidylcholine.
【0018】[0018]
【表1 】 【table 1 】
【0019】生成したホスファチジルコリンのSn2位
の脂肪酸組成は、エイコサペンタエン酸(C20-5)が1
6.0%、ドコサヘキサエン酸(C22-6)が9.5%であ
り、基質魚油脂肪酸の組成とほぼ等しかった。The fatty acid composition at the Sn2 position of the produced phosphatidylcholine was 1% for eicosapentaenoic acid (C20-5).
The content was 6.0% and the content of docosahexaenoic acid (C22-6) was 9.5%, which was almost the same as the composition of the substrate fish oil fatty acid.
【0020】[0020]
【実施例2】脂肪酸を高度不飽和脂肪酸濃縮脂肪酸(エ
イコサペンタエン酸(EPA)とドコサヘキサエン酸
(DHA)の合計が、全体の65%以上)に変えた以外
は、実施例1と同様に反応を行った。その結果、ホスフ
ァチジルコリン合成率は14.8%であった。原料のリ
ゾホスファチジルコリン、高度不飽和脂肪酸濃縮脂肪酸
の脂肪酸組成を表2に示した。Example 2 A reaction was performed in the same manner as in Example 1 except that the fatty acid was changed to a highly unsaturated fatty acid concentrated fatty acid (the total amount of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) was 65% or more of the total). went. As a result, the phosphatidylcholine synthesis rate was 14.8%. Table 2 shows the fatty acid composition of lysophosphatidylcholine and polyunsaturated fatty acid-enriched fatty acid as raw materials.
【0021】[0021]
【表2】 [Table 2]
【0022】生成したホスファチジルコリンのSn2位
の脂肪酸組成を分析したところEPA(C20−5)、
DHA(C22−6)がそれぞれ43.2%、25.3
%であり基質脂肪酸の組成とほぼ等しかった。When the composition of fatty acids at the Sn2 position of the phosphatidylcholine produced was analyzed, EPA (C20-5),
DHA (C22-6) was 43.2% and 25.3%, respectively.
%, Which was almost the same as the composition of the substrate fatty acid.
【0023】[0023]
【実施例3】脂肪酸をEPA(純度99%以上)に変えた
以外は、実施例1と同様に反応を行った。その結果、ホ
スファチジルコリン合成率は15.9%であり、生成し
たホスファチジルコリンのSn2位の脂肪酸組成を分析
したところ、そのほとんどがEPAであった。[Example 3] The reaction was performed in the same manner as in Example 1 except that the fatty acid was changed to EPA (purity 99% or more). As a result, the phosphatidylcholine synthesis rate was 15.9%, and when the composition of fatty acids at the Sn2 position of the phosphatidylcholine produced was analyzed, most of them were EPA.
【0024】[0024]
【発明の効果】叙上のように、リン脂質の合成に関する
もので、グリセロールを添加することにより酵素による
合成が進行し、化学合成法と比較して高度不飽和脂肪酸
の変性・分解の少ない、Sn2位に高度不飽和脂肪酸を
有する生理活性の高いリン脂質を得ることができる。As described above, the present invention relates to the synthesis of phospholipids, in which the addition of glycerol promotes the enzymatic synthesis, resulting in less denaturation / degradation of highly unsaturated fatty acids as compared with the chemical synthesis method. A highly physiologically active phospholipid having a highly unsaturated fatty acid at the Sn2 position can be obtained.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 赤澤 治夫 東京都千代田区有楽町1丁目12番1号 株 式会社ニチロ中央研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Haruo Akazawa 1-12-1 Yurakucho, Chiyoda-ku, Tokyo Inventor Nichiro Central Research Institute
Claims (1)
脂質と、高度不飽和脂肪酸又はそのエステルとから、酵
素ホスホリパーゼA2 の酵素反応によりSn2位に高度
不飽和脂肪酸を有するリン脂質を得る際、反応系にグリ
セロールを添加することを特徴とする高度不飽和脂肪酸
含有リン脂質の製造方法。1. When obtaining a phospholipid having a highly unsaturated fatty acid at the Sn2 position by enzymatic reaction of the enzyme phospholipase A 2 from a lyso-type phospholipid having an acyl group at the Sn1 position and a highly unsaturated fatty acid or an ester thereof. And a method for producing a highly unsaturated fatty acid-containing phospholipid, which comprises adding glycerol to the reaction system.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9127291A JPH05236974A (en) | 1991-03-29 | 1991-03-29 | Production of highly unsaturated fatty acid-containing phospholipid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9127291A JPH05236974A (en) | 1991-03-29 | 1991-03-29 | Production of highly unsaturated fatty acid-containing phospholipid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH05236974A true JPH05236974A (en) | 1993-09-17 |
Family
ID=14021816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9127291A Pending JPH05236974A (en) | 1991-03-29 | 1991-03-29 | Production of highly unsaturated fatty acid-containing phospholipid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH05236974A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997028270A1 (en) * | 1996-02-02 | 1997-08-07 | Biomolecular Products, Inc. | Methods for making lysophosphatidylcholine |
US5891466A (en) * | 1990-08-13 | 1999-04-06 | Yesair; David W. | Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories |
US6346276B1 (en) | 1997-10-24 | 2002-02-12 | Asahi Kasei Kabushiki Kaisha | Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substances |
JP2002188096A (en) * | 2000-10-12 | 2002-07-05 | Kanegafuchi Chem Ind Co Ltd | New glyceride, method for producing the same and its use |
JP2010068799A (en) * | 2008-08-22 | 2010-04-02 | Kaneka Corp | Method for producing phospholipid |
WO2011004794A1 (en) | 2009-07-06 | 2011-01-13 | 株式会社カネカ | Method for producing phospholipid |
JP2016053156A (en) * | 2014-09-02 | 2016-04-14 | 日清ファルマ株式会社 | Production method of polyunsaturated fatty acid-binding phospholipid |
-
1991
- 1991-03-29 JP JP9127291A patent/JPH05236974A/en active Pending
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891466A (en) * | 1990-08-13 | 1999-04-06 | Yesair; David W. | Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories |
WO1997028270A1 (en) * | 1996-02-02 | 1997-08-07 | Biomolecular Products, Inc. | Methods for making lysophosphatidylcholine |
US6346276B1 (en) | 1997-10-24 | 2002-02-12 | Asahi Kasei Kabushiki Kaisha | Composition containing useful substances originating in fishes and shellfishes and process for the preparation of the substances |
JP2002188096A (en) * | 2000-10-12 | 2002-07-05 | Kanegafuchi Chem Ind Co Ltd | New glyceride, method for producing the same and its use |
JP2010068799A (en) * | 2008-08-22 | 2010-04-02 | Kaneka Corp | Method for producing phospholipid |
WO2011004794A1 (en) | 2009-07-06 | 2011-01-13 | 株式会社カネカ | Method for producing phospholipid |
CN102471788A (en) * | 2009-07-06 | 2012-05-23 | 株式会社钟化 | Method for producing phospholipid |
JP4978751B2 (en) * | 2009-07-06 | 2012-07-18 | 株式会社カネカ | Method for producing phospholipid |
US8530208B2 (en) | 2009-07-06 | 2013-09-10 | Kaneka Corporation | Method for producing phospholipid |
JP2016053156A (en) * | 2014-09-02 | 2016-04-14 | 日清ファルマ株式会社 | Production method of polyunsaturated fatty acid-binding phospholipid |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8877465B2 (en) | Production of ultrapure EPA and polar lipids from largely heterotrophic culture | |
HU229062B1 (en) | Process for preparing docosahexaenoic acid and docosapentaenoic acid | |
CN101037641A (en) | Process for producing fat comprising triglyceride containing highly unsaturated fatty acid | |
Bogojevic et al. | Designer phospholipids–structural retrieval, chemo-/bio-synthesis and isotopic labeling | |
US20100216197A1 (en) | Microbial fermentation-based production of phospholipids containing long-chain polyunsaturated fatty acids as their constituents | |
US5153125A (en) | Process for producing lysophospholipids-containing phospholipids with reduced neutral lipid content | |
JPH05236974A (en) | Production of highly unsaturated fatty acid-containing phospholipid | |
JP6025143B2 (en) | 2-Acyl-lysophosphatidylserine-containing composition and method for producing the same | |
JPH08214892A (en) | Production of partial glyceride containing highly unsaturated fatty acid | |
JP3689443B2 (en) | Process for producing highly unsaturated fatty acid-containing glycerides | |
JPH0387191A (en) | Production of phosphatidylinositol | |
JP2001186898A (en) | Method for producing phosphatidyl serine having polyvalent unsaturated fatty acid residue | |
JPH02501622A (en) | Method for producing cis-9-octadecenoic acid composition | |
JP5041790B2 (en) | Process for producing phosphatidylserine having polyunsaturated fatty acid as a constituent | |
JP5371750B2 (en) | Method for producing DHA-containing phospholipids by microbial fermentation | |
KR100850646B1 (en) | Manufacturing method of phospholipid composition | |
JP3861941B2 (en) | Oil composition containing highly unsaturated fatty acid with improved hydration | |
JP2008125365A (en) | Method for preparing high-purity plasmologen | |
JP4266644B2 (en) | Method for producing phosphatidylserine | |
JP2001245687A (en) | Lipid containing n-4 and/or n-7 highly unsaturated fatty acid and method for producing the lipid | |
JP2006197842A (en) | Composition having phospholipase a1 activity, 2-acyl type lysophospholipid obtained by using the same and method for producing those | |
JPH0216989A (en) | Production of omega6-based unsaturated fatty acid-containing phospholipid | |
PL239132B1 (en) | Method of enzymatic enrichment of lecithin in a conjugated linoleic acid isomer | |
PL239133B1 (en) | Method of enzymatic enrichment of lecithin in a conjugated linoleic acid isomer | |
JPH0856683A (en) | Method for synthesizing lipid containing highly unsaturated fatty acid |